Steven Cohen’s Atrium Therapeutics RNA Stock Holding History
Bought
Maintained
Sold
Other funds holding RNA
Steven Cohen's RNA Position: Q3 2026 in Review
Steven Cohen opened a new position in Atrium Therapeutics (RNA) in Q3 2026: 28,917 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #3443 among its holdings. This is a return to the name: Steven Cohen previously reported a position in RNA as recently as Q1 2026.
Steven Cohen first reported a position in RNA in Q1 2026 and has held it in 2 quarters since. The position peaked at $304K in Q1 2026. 148 funds tracked by Wall St. Rank hold RNA as of Q3 2026.
- Steven Cohen held 28,917 shares of Atrium Therapeutics worth $239K as of Q3 2026.
- Atrium Therapeutics was a new Steven Cohen position in Q3 2026.
- Atrium Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3443 holding.
- Steven Cohen first reported a position in Atrium Therapeutics in Q1 2026 and has held it in 2 quarters since.
- Steven Cohen's Atrium Therapeutics position peaked at $304K in Q1 2026.
- 148 funds tracked by Wall St. Rank held Atrium Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.